SCHEMBL8737656

SCHEMBL8737656

O=S(=O)(Oc1ccc(C2CCCCC2)cc1)C(F)(F)C(F)(F)C(F)(F)SOO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41
DRD5 P21918 1/20 0.41
DRD3 P35462 1/20 0.41
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
THRB P10828 1/20 0.34
KDM1A O60341 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ENPP3 O14638 3/20 0.33
ENPP2 Q13822 2/20 0.33
ENPP1 P22413 2/20 0.33
PDK2 Q15119 1/20 0.33
FAAH O00519 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825692 0.91 DRD2 (0.39) DRD2DRD1DRD4DRD5DRD3
SCHEMBL12254590 0.85 DRD2 (0.41) DRD2DRD1DRD4DRD5DRD3
SCHEMBL1687750 0.82 DRD2 (0.46) DRD2DRD1DRD4DRD5DRD3
SCHEMBL2887915 0.82 DRD2 (0.45) DRD2DRD1DRD4DRD5DRD3
SCHEMBL6047885 0.81 DRD2 (0.44) DRD2DRD1DRD4DRD5DRD3
SCHEMBL110631 0.81 DRD2 (0.47) DRD2DRD1DRD4DRD5DRD3
SCHEMBL14028984 0.81 DRD2 (0.41) DRD2DRD1DRD4DRD5DRD3
SCHEMBL14013662 0.80 DRD2 (0.46) DRD2DRD1DRD4DRD5DRD3
SCHEMBL17707967 0.80 DRD2 (0.44) DRD2DRD1DRD4DRD5DRD3
SCHEMBL13898699 0.80 DRD2 (0.46) DRD2DRD1DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME ACTR8, RAD51, ACTR2 DRD2 1429/4885DRD1 1760/4885DRD4 2711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.